ERYTHROPOIETIN RECEPTOR ANTAGONISTS

摘要

The present invention provides erythropoietin derived peptides which bind the erythropoietin receptor and inhibit EPO-induced cell proliferation. The invention further provides pharmaceutical compositions comprising same, and uses thereof in the treatment of primary and secondary erythrocytosis as well as for inhibiting undesirable cell proliferation induced by erythropoietin receptor in patients treated with erythropoietin.